Soner Şenel

842 total citations
29 papers, 328 citations indexed

About

Soner Şenel is a scholar working on Molecular Biology, Surgery and Rheumatology. According to data from OpenAlex, Soner Şenel has authored 29 papers receiving a total of 328 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Molecular Biology, 8 papers in Surgery and 8 papers in Rheumatology. Recurrent topics in Soner Şenel's work include Inflammasome and immune disorders (13 papers), Inflammatory Biomarkers in Disease Prognosis (5 papers) and Gout, Hyperuricemia, Uric Acid (4 papers). Soner Şenel is often cited by papers focused on Inflammasome and immune disorders (13 papers), Inflammatory Biomarkers in Disease Prognosis (5 papers) and Gout, Hyperuricemia, Uric Acid (4 papers). Soner Şenel collaborates with scholars based in Türkiye, United Kingdom and Finland. Soner Şenel's co-authors include A. Uslu, Şafak Şahin, Mehmet Şencan, Serdal Korkmaz, Enver Sancakdar, Köksal Deveci, Hülya Toker, Hilmi Ataseven, Hüseyin Aydın and Hakan Özdemir and has published in prestigious journals such as SHILAP Revista de lepidopterología, Scientific Reports and Annals of the Rheumatic Diseases.

In The Last Decade

Soner Şenel

27 papers receiving 315 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Soner Şenel Türkiye 11 160 87 64 63 61 29 328
Naoto Azuma Japan 10 77 0.5× 23 0.3× 110 1.7× 61 1.0× 75 1.2× 46 313
Vasiliki-Kalliopi Bournia Greece 15 79 0.5× 28 0.3× 255 4.0× 74 1.2× 114 1.9× 35 589
Gülay Kınıklı Türkiye 12 84 0.5× 38 0.4× 221 3.5× 42 0.7× 101 1.7× 55 477
M. Maset Italy 7 35 0.2× 58 0.7× 185 2.9× 193 3.1× 72 1.2× 12 495
Gláucio Ricardo Werner de Castro Brazil 13 72 0.5× 49 0.6× 195 3.0× 40 0.6× 79 1.3× 38 390
Eduardo Martín‐Nares Mexico 13 88 0.6× 26 0.3× 237 3.7× 130 2.1× 56 0.9× 43 538
Filipe Barcelos Portugal 10 35 0.2× 40 0.5× 145 2.3× 63 1.0× 59 1.0× 31 370
Susumu Nishiyama Japan 11 31 0.2× 32 0.4× 135 2.1× 76 1.2× 63 1.0× 42 356
Riham El Sayed Egypt 9 77 0.5× 47 0.5× 25 0.4× 34 0.5× 89 1.5× 21 305
Rosa Morlà Spain 12 35 0.2× 35 0.4× 250 3.9× 82 1.3× 62 1.0× 25 448

Countries citing papers authored by Soner Şenel

Since Specialization
Citations

This map shows the geographic impact of Soner Şenel's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Soner Şenel with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Soner Şenel more than expected).

Fields of papers citing papers by Soner Şenel

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Soner Şenel. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Soner Şenel. The network helps show where Soner Şenel may publish in the future.

Co-authorship network of co-authors of Soner Şenel

This figure shows the co-authorship network connecting the top 25 collaborators of Soner Şenel. A scholar is included among the top collaborators of Soner Şenel based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Soner Şenel. Soner Şenel is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Çefle, Ayşe, Fatoş Önen, Nurullah Akkoç, et al.. (2024). Biological treatment in elderly and young patients with ankylosing spondylitis: TURKBIO real-life data results. Archives of Rheumatology. 39(2). 232–241. 4 indexed citations
2.
Karataş, Ahmet, Süleyman Serdar Koca, Ediz Dalkılıç, et al.. (2023). Body mass index does not affect response of rituximab in patients with rheumatoid arthritis: results from the TURKBİO registry. TURKISH JOURNAL OF MEDICAL SCIENCES. 53(5). 1321–1329.
4.
Eroğlu, Eray, Murat Hayri Sipahioğlu, Soner Şenel, et al.. (2019). Successful treatment of tubulointerstitial nephritis in immunoglobulin G4-related disease with rituximab: A case report. World Journal of Clinical Cases. 7(16). 2309–2315. 3 indexed citations
5.
Çetin, Gözde Yıldırım, Timuçin Kaşifoğlu, Eren Erken, et al.. (2018). Exon 2: Is it the good police in familial mediterranean fever?. SHILAP Revista de lepidopterología. 6(1). 34–37. 11 indexed citations
6.
Küçük, Adem, et al.. (2016). The role of neutrophil lymphocyte ratio to leverage the differential diagnosis of familial Mediterranean fever attack and acute appendicitis. The Korean Journal of Internal Medicine. 31(2). 386–391. 18 indexed citations
7.
Toker, Hülya, et al.. (2016). Evaluation of IL-1β, IL-1ra, and IL-10 levels and outcome of periodontal therapy in chronic periodontitis with familial Mediterranean fever. Clinical Oral Investigations. 21(1). 469–475. 21 indexed citations
8.
Mercan, Rıdvan, Kevser Gök, Ahmet Mesut Onat, et al.. (2016). The management of gout in different clinical specialties in Turkey: a patient-based survey. Clinical Rheumatology. 35(12). 3019–3024. 1 indexed citations
9.
Akar, Servet, Bünyamin Kısacık, Ş Apraş, et al.. (2014). THU0072 Comparison of Characteristics of Ankylosing Spondylitis in Association with Familial Mediterranean Fever with Those of Typical Ankylosing Spondylitis. Annals of the Rheumatic Diseases. 73. 201–202. 2 indexed citations
10.
Şahin, Şafak, Soner Şenel, & Saadettin Kılıçkap. (2014). Is Familial Mediterranean fever a risk factor for Malignant Peritoneal Mesothelioma: a Case Presentation and Literature Review. 3(1). 67–69. 1 indexed citations
11.
Deveci, Köksal, Serdal Korkmaz, Soner Şenel, et al.. (2013). Do neutrophil gelatinase-associated lipocalin and interleukin-18 predict renal dysfunction in patients with familial Mediterranean fever and amyloidosis?. Renal Failure. 36(3). 339–344. 6 indexed citations
12.
Uysal, İsmail Önder, et al.. (2013). Evaluation of hearing in patients with familial Mediterranean fever. European Archives of Oto-Rhino-Laryngology. 270(11). 2871–2874. 10 indexed citations
13.
Şahin, Şafak, et al.. (2013). Assesment life quality of familial Mediterranean fever patients by short form-36 and its relationship with disease parameters.. PubMed. 17(7). 958–63. 28 indexed citations
14.
Korkmaz, Serdal, A. Uslu, Şafak Şahin, Soner Şenel, & Mehmet Şencan. (2013). Is there a link between mean platelet volume and thrombotic events in antiphospholipid syndrome?. Platelets. 25(5). 343–347. 9 indexed citations
15.
Şahin, Şafak, et al.. (2012). Does mean platelet volume influence the attack or attack-free period in the patients with Familial Mediterranean fever?. Platelets. 24(4). 320–323. 21 indexed citations
16.
Öztürk, Mehmet Akif, Arif Kaya, Soner Şenel, et al.. (2012). Demographic and clinical features of gout patients in Turkey: a multicenter study. Rheumatology International. 33(4). 847–852. 12 indexed citations
17.
Şenel, Soner, et al.. (2011). Bone mineral density in familial Mediterranean fever. Rheumatology International. 32(8). 2453–2457. 6 indexed citations
19.
Zorlu, Pelin, et al.. (2009). A rare subtelomeric deletion syndrome: Wolf Hirschhorn syndrome.. PubMed. 25(3). 299–303. 2 indexed citations
20.
Şenel, Soner, Emın Kaya, Ismet Aydogdu, Mehmet Ali Erkurt, & İrfan Kuku. (2006). Rheumatic diseases and chronic myelogenous leukemia, presentation of four cases and review of the literature. Rheumatology International. 26(9). 857–861. 10 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026